Lv1
20 积分 2025-03-24 加入
Immunology and immunotherapy of cholangiocarcinoma
9个月前
已完结
Anti-programmed cell death-1 and anti-programmed cell death ligand-1 immune-related liver diseases: from clinical pivotal studies to real-life experience
9个月前
已关闭
Antibody-drug conjugates-related interstitial lung diseases: data mining of the FAERS database
9个月前
已完结
The safety of trastuzumab deruxtecan (DS‐8201) with a focus on interstitial lung disease and/or pneumonitis: A systematic review and single‐arm meta‐analysis
9个月前
已完结
Lung toxicity induced by anti-HER2 antibody – drug conjugates for breast cancer
9个月前
已完结
Dry Eye Syndrome Preferred Practice Pattern®
9个月前
已完结
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
9个月前
已完结
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population
9个月前
已完结
皖公网安备34019202002308
